Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Yale Podnos currently holds 284,783 shares of Oncology Institute, Inc. (TOI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Yale Podnos has been a net seller of TOI stock. They have purchased $0 and sold $404 worth of shares.
Yale Podnos's most recent insider trade was on Mar 27, 2026, when they sold 16,173 shares at $3.07 per share.
Yale Podnos serves as Executive at Oncology Institute, Inc. (TOI). They have executed 18 insider transactions totaling $404 over their tenure at the company.
Yale Podnos holds the position of Executive at Oncology Institute, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 4 years and currently hold a stake valued at $0.
Yale Podnos has shown a selling trading pattern, with $0 in total purchases and $404 in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Yale Podnos was on Mar 27, 2026, when they sold $49.7K worth of TOI shares. This transaction involved 16,173 shares at $3.07 per share.
Yale Podnos currently owns 284,783 shares of Oncology Institute, Inc. (TOI), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Yale Podnos's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Yale Podnos has 18 Form 4 filings on record as an insider at Oncology Institute, Inc..
Set alerts for Yale Podnos and 40,000+ other insiders.